Secondary |
Ill-defined Disorder |
26.4% |
Product Used For Unknown Indication |
13.2% |
Drug Use For Unknown Indication |
10.9% |
Arterial Disorder |
4.7% |
Carotid Artery Thrombosis |
4.7% |
Drug Toxicity |
4.7% |
Ischaemic Stroke |
4.7% |
Depression |
3.9% |
Intentional Overdose |
3.1% |
Ischaemia |
3.1% |
Analgesia |
2.3% |
Constipation |
2.3% |
Dyslipidaemia |
2.3% |
Dysthymic Disorder |
2.3% |
Muscle Spasticity |
2.3% |
Musculoskeletal Pain |
2.3% |
Pain In Extremity |
2.3% |
Abdominal Pain |
1.6% |
Essential Hypertension |
1.6% |
Essential Thrombocythaemia |
1.6% |
|
Vascular Purpura |
11.4% |
Epilepsy |
8.6% |
Thrombocytopenia |
8.6% |
Tremor |
8.6% |
Cytolytic Hepatitis |
5.7% |
Hiccups |
5.7% |
Malaise |
5.7% |
Serotonin Syndrome |
5.7% |
Ulcer |
5.7% |
Vomiting |
5.7% |
Hyponatraemia |
2.9% |
Hypotension |
2.9% |
Hypothyroidism |
2.9% |
Multiple Drug Overdose Intentional |
2.9% |
Pain |
2.9% |
Pruritus |
2.9% |
Renal Failure |
2.9% |
Sepsis |
2.9% |
Suicide Attempt |
2.9% |
Tachycardia |
2.9% |
|
Concomitant |
Drug Use For Unknown Indication |
52.6% |
Product Used For Unknown Indication |
7.9% |
Hypertension |
6.5% |
Pain |
3.8% |
Dementia Alzheimer's Type |
2.8% |
Ill-defined Disorder |
2.6% |
Non-small Cell Lung Cancer |
2.3% |
Prostate Cancer |
2.3% |
Arterial Disorder |
2.1% |
Insomnia |
2.1% |
Premedication |
2.1% |
Gastric Cancer |
1.7% |
Gout |
1.7% |
Diabetes Mellitus |
1.6% |
Pulmonary Arterial Hypertension |
1.6% |
Type 2 Diabetes Mellitus |
1.6% |
Benign Prostatic Hyperplasia |
1.4% |
Dyslipidaemia |
1.2% |
Arterial Occlusive Disease |
1.0% |
Hepatic Neoplasm Malignant |
1.0% |
|
Renal Failure Acute |
16.9% |
Renal Failure |
9.1% |
Septic Shock |
6.5% |
Fall |
5.2% |
Gastrointestinal Obstruction |
5.2% |
Toe Amputation |
5.2% |
Vascular Purpura |
5.2% |
Peripheral Ischaemia |
3.9% |
Syncope |
3.9% |
Tachycardia |
3.9% |
Thrombocytopenia |
3.9% |
Thrombophlebitis Superficial |
3.9% |
Thrombosis |
3.9% |
Transient Ischaemic Attack |
3.9% |
Tremor |
3.9% |
Urinary Tract Malformation |
3.9% |
Vomiting |
3.9% |
Drug Rash With Eosinophilia And Systemic Symptoms |
2.6% |
Haematoma |
2.6% |
Haematuria |
2.6% |
|
Interacting |
Neuralgia |
25.0% |
Arterial Disorder |
16.7% |
Dyslipidaemia |
16.7% |
Depression |
8.3% |
Diabetes Mellitus Non-insulin-dependent |
8.3% |
Hypertension |
8.3% |
Insomnia |
8.3% |
Pain |
8.3% |
|
Weight Increased |
66.7% |
Toxic Skin Eruption |
33.3% |
|